Arkolith/Insider Trading/SANA/Form 4

Wyrick Susan D.

See RemarksSana Biotechnology, Inc. (SANA) · full profile →Form 4 · filed Mar 3, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2025Tax withholding(F)490$2.56$1K155K
Mar 2, 2025Option exercise(M)2K—$0155K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 2, 2025Option exercise(M)2K—$03K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-25-001888) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML